The development of novel and selective p56(lck) tyrosine kinase inhibitors

James L. Bullington, Julie C. Cameron, Janet E. Davis, John H. Dodd, Crafford A. Harris, James R. Henry, J. Lee Pellegrino-Gensey, Kenneth C. Rupert, John J. Siekierka

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Early T-cell receptor mediated signal transduction involves the activation of several tyrosine protein kinases. One of these tyrosine kinases, p56(lck), is expressed primarily in T-cells and Natural Killer (NK) cells and has been shown to be critical for their proliferative and effector functions. Indandiones have been identified as a potent and selective chemical class that inhibits p56(lck).

Original languageEnglish
Pages (from-to)2489-2494
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume8
Issue number18
DOIs
StatePublished - 22 Sep 1998

Fingerprint Dive into the research topics of 'The development of novel and selective p56(lck) tyrosine kinase inhibitors'. Together they form a unique fingerprint.

  • Cite this

    Bullington, J. L., Cameron, J. C., Davis, J. E., Dodd, J. H., Harris, C. A., Henry, J. R., Pellegrino-Gensey, J. L., Rupert, K. C., & Siekierka, J. J. (1998). The development of novel and selective p56(lck) tyrosine kinase inhibitors. Bioorganic and Medicinal Chemistry Letters, 8(18), 2489-2494. https://doi.org/10.1016/S0960-894X(98)00445-4